308 related articles for article (PubMed ID: 25323535)
1. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
[TBL] [Abstract][Full Text] [Related]
2. LIF is a new p53 negative regulator.
Liu J; Yu H; Hu W
J Nat Sci; 2015; 1(7):e131. PubMed ID: 26161442
[TBL] [Abstract][Full Text] [Related]
3. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.
Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z
Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859
[TBL] [Abstract][Full Text] [Related]
5. Magnolin promotes autophagy and cell cycle arrest via blocking LIF/Stat3/Mcl-1 axis in human colorectal cancers.
Yu H; Yin S; Zhou S; Shao Y; Sun J; Pang X; Han L; Zhang Y; Gao X; Jin C; Qiu Y; Wang T
Cell Death Dis; 2018 Jun; 9(6):702. PubMed ID: 29899555
[TBL] [Abstract][Full Text] [Related]
6. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
7. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.
Meng J; Liu K; Shao Y; Feng X; Ji Z; Chang B; Wang Y; Xu L; Yang G
Cell Death Dis; 2020 Feb; 11(2):137. PubMed ID: 32080166
[TBL] [Abstract][Full Text] [Related]
8. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.
Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M
Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3.
Liu B; Lu Y; Li J; Liu Y; Liu J; Wang W
APMIS; 2015 Oct; 123(10):837-46. PubMed ID: 26271643
[TBL] [Abstract][Full Text] [Related]
12. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
13. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
14. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
16. p53: a new player in reproduction.
Hu W; Feng Z; Atwal GS; Levine AJ
Cell Cycle; 2008 Apr; 7(7):848-52. PubMed ID: 18414047
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms.
Wang H; Nan L; Yu D; Lindsey JR; Agrawal S; Zhang R
Mol Med; 2002 Apr; 8(4):185-99. PubMed ID: 12149568
[TBL] [Abstract][Full Text] [Related]
18. MDM2-p53 mediate a miR-181c-3p/LIF axis to regulate low dose-rate radiation-induced DNA damage in human B lymphocytes.
Chen Y; Gong Y; Qin H; Wei S; Wei Y; Yu Y; Lin X; Shuai P; Wang T; Guo C; Wang Q; Li G; Meng L; Yi L
Ecotoxicol Environ Saf; 2024 Jan; 270():115848. PubMed ID: 38134636
[TBL] [Abstract][Full Text] [Related]
19. STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (
Lin Z; Liu Y; Xu T; Su T; Yang Y; Liang R; Gu S; Li J; Song X; Liang B; Leng Z; Li Y; Meng L; Luo Y; Chang X; Huang D; Xie L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373188
[TBL] [Abstract][Full Text] [Related]
20. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer.
Choi TG; Nguyen MN; Kim J; Jo YH; Jang M; Nguyen NNY; Yun HR; Choe W; Kang I; Ha J; Tang DG; Kim SS
J Pathol; 2018 Sep; 246(1):115-126. PubMed ID: 29876924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]